Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Assay Kit / ADA/PK Assay Elisa Kit

Human Anti-Monkeypox Virus (MPXV) IgG ELISA Kit (M1R) (KAV13301)

Sample type:Plasma, Serum
Range:15.6 ng/mL - 1,000 ng/mL
Overview

Description

PRINCIPLE OF THE ASSAY This assay employs the quantitative competitive enzyme immunoassay technique. Recombinant Monkeypox virus M1R antigen has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Human Anti-Monkeypox virus IgG (M1R) in the sample competitively binds to the pre-coated protein with biotin-labeled Human Anti-Monkeypox virus IgG (M1R). After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Human Anti-Monkeypox virus IgG (M1R) bound in the initial step. The color development is stopped and the intensity of the color is measured.

Catalog No.

KAV13301

Tested applications

Used for the quantitative determination of Human Anti-Monkeypox virus IgG (M1R) concentration in serum and plasma.

Target

M1R

Stability and Storage

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.

Detection method

Colorimetric

Precision

MATERIALS PROVIDED & STORAGE CONDITIONS

PART

Format

Description

STORAGE CONDITIONS

Pre-coated Microplate

1 plate

96 well polystyrene microplate (12 strips of 8 wells) precoated with recombinant Monkeypox virus M1R antigen.

Store in sealed at -20℃.

Human Anti-Monkeypox virus IgG (M1R) Standard

2 bottles

1,000 ng/bottle of lyophilized Human Anti-Monkeypox virus IgG (M1R). Reconstitute in 1mL Standard Diluent before used.

Store at -20℃.

Detection A

1 vial

60 μL/vial of Biotin labeled Human Anti-Monkeypox virus IgG (M1R) antibody (including preservative), 1:100 diluted by Assay Diluent before used.

Store at -20℃.

Detection B

1 vial

120 μL/vial of Streptavidin-HRP (including preservative), 1:100 diluted by Assay Diluent before used.

Store at -20℃.

Standard Diluent

1 bottle

25 mL/bottle diluent (including preservative) was used to dilute the Standard and Samples.

Store at 4℃.

Assay Diluent

1 bottle

25 mL/bottle diluent (including preservative) was used to dilute the Detection A and Detection B.

Store at 4℃.

20 × Wash Buffer

1 bottle

25 mL/bottle of a 20-fold concentrated solution of buffered surfactant with preservative, 1:20 diluted by deionized water before used.

Store at 4℃.

Color Reagent

1 bottle

12 mL/ bottle of TMB (Tetramethylbenzidine).

Store at 4℃.

Stop Solution

1 bottle

6 mL/ bottle.

Store at 4℃.

Plate Sealers

4 strips

Adhesive strips.

Store at RT.

* Provided this is within the expiration date of the kit.

 

OTHER SUPPLIES REQUIRED

• Microplate reader capable of measuring absorbance at 450 nm, with the correction wavelength set at 630 nm or 620 nm.

• Pipettes and pipette tips.

• Deionized or distilled water.

• 500 mL graduated cylinder.

• Squirt bottle, manifold dispenser, or automated microplate washer.

• Test tubes for dilution of standards.

 

SAMPLE COLLECTION & STORAGE

The sample collection and storage conditions listed below are intended as general guidelines. Sample stability has not been evaluated.

Handle all blood and serum as if capable of transmitting infectious agents. The NCCLS provides recommendations for handling and storing serum and plasma specimens (Approved Standard-Procedures for the Handling and Processing of Blood Specimens, H18-A. 1990).

Serum - Use a serum separator tube (SST) and allow samples to clot for 30 minutes at room temperature before centrifugation for 15 minutes at 1000 x g. Remove serum and assay immediately or aliquot and store samples at ≤ -20℃. Avoid repeated freeze-thaw cycles.

Plasma - Collect plasma using EDTA, heparin, or citrate as an anticoagulant. Centrifuge for 15 minutes at 1000 x g within 30 minutes of collection. Assay immediately or aliquot and store samples at ≤ -20℃. Avoid repeated freeze-thaw cycles.

 

REAGENT PREPARATION

Bring all reagents to room temperature before use.

20-fold Wash Buffer Concentrate - If crystals have formed in the concentrate, warm to room temperature and mix gently until the crystals have completely dissolved. Add 25 mL of Wash Buffer Concentrate to 475 mL of deionized or distilled water to prepare 500 mL of Wash Buffer.

Serum and Plasma - Serum and plasma samples require a 10-fold dilution. A suggested 10-fold dilution is 10 μL of sample + 90 μL of Standard Diluent (diluted 1:9). If the sample value is outside the range of the standard curve, the dilution can be adjusted appropriately and the assay can be redetermined. If the antibody concentration in the sample can be estimated and the assay can be performed simultaneously by diluting several gradients prior to the experiment.

Standard - Reconstitute with 1mL Standard Diluent, this reconstitution produces a stock solution of  1,000 ng/mL. Allow the standard to sit for a minimum of 15 minutes with gentle agitation prior to making dilutions. 1,000 ng/mL is the first standard point, and the concentration of the 7 standard sample were  1,000 ng/mL, 500 ng/mL, 250 ng/mL, 125 ng/mL, 62.5 ng/mL, 31.25 ng/mL, 15.6 ng/mL respectively. The appropriate Standard Diluent serves as the zero standard (0 ng/mL).

Detection A (working solution) - Shake and mix before used. Centrifuge instantaneously with palm centrifuge to make the liquid at the bottom of the tube. Dilute the Detection A 1: 100 times to the working concentration with Assay Diluent.

Detection B (working solution) - Shake and mix before used. Centrifuge instantaneously with palm centrifuge to make the liquid at the bottom of the tube. Dilute the Detection B 1: 100 times to the working concentration with Assay Diluent.

ASSAY PROCEDURE

Bring all reagents and samples to room temperature before use. It is recommended that all standards and samples be assayed in duplicate.

1. Prepare all reagents and working standards as directed in the previous sections.

2. Remove excess microplate strips from the plate frame, return them to the foil pouch containing the desiccant pack, and reseal.

3. Add 100 μL premixed solution (50 μL diluted standard/sample + 50 μL Detection A working solution) to each well. Cover with the adhesive strip provided. Incubate for 2 hours at 37℃.

4. Aspirate each well and wash, repeating the process three times. Wash by filling each well with Wash Buffer (300 μL) using a squirt bottle, manifold dispenser, or autowasher. Complete removal of liquid at each step is essential to good performance. After the last wash, remove any remaining Wash Buffer by aspirating or decanting. Invert the plate and blot it against clean paper towels.

5. Add 100 μL of Detection B (working solution) to each well. Cover with a new adhesive strip. Incubate for 30 minutes at 37℃.

6. Aspirate each well and wash, repeating the process five times. Wash by filling each well with Wash Buffer (300 μL) using a squirt bottle, manifold dispenser, or autowasher. Complete removal of liquid at each step is essential to good performance. After the last wash, remove any remaining Wash Buffer by aspirating or decanting. Invert the plate and blot it against clean paper towels.

7. Add 100 μL of Color Reagent to each well. Incubate for 15 minutes at 37℃. Protect from light.

8. Add 50 μL of Stop Solution to each well. The color in the wells should change from blue to yellow. If the color in the wells is green or the color change does not appear uniform, gently tap the plate to ensure thorough mixing.

9. Determine the optical density of each well within 10 minutes, using a microplate reader set to 450 nm. If wavelength correction is available, set to 630 nm or 620 nm. If wavelength correction is not available, subtract readings at 630 nm or 620 nm from the readings at 450 nm. This subtraction will correct for optical imperfections in the plate. Readings made directly at 450 nm without correction may be higher and less accurate.

 

PRECISION

Intra-Assay Precision (Precision within an assay): <20%

Three samples of known concentration were tested sixteen times on one plate to assess intra-assay precision.

Inter-Assay Precision (Precision between assays): <20%

Three samples of known concentration were tested in twenty four separate assays to assess inter-assay precision.

 

TROUBLESHOOTING GUIDE

Problem

Probable Cause

Solution

Poor Precision

Wells are not washed or aspirated properly

Make sure the wash apparatus works properly and wells are dry after aspiration

Bubbles in the wells

Tap plate gently to disperse bubbles

Wells are scratched with pipette tip or washing needles

Dispense and aspirate solution into and out of wells with caution

Particulates are found in the samples

Remove any particulates by centrifugation prior to the assay

High background

Plate is not washed properly

Make sure the wash apparatus works properly

Incorrect incubation times and/or temperatures

The OD value increased gradually along with the time. Reduce the color developing time properly

 

Weak/No Signal

Pipetting errors

Make sure the pipette is calibrated

The working solution not be prepared immediately before use

The working solution should be prepared immediately before use and should not be stored

Volumes errors

Repeat assay with the required volumes in manual

The plate is not incubated for proper time or temperature

Follow the manual to repeat assay

Detection A working solution is not completely mixed with the samples

After adding the Detection A into the wells, make sure the detection A and the samples are mixed thoroughly

 

 

Sample type

Plasma, Serum

Assay type

Quantitative

Range

15.6 ng/mL - 1,000 ng/mL

Recovery

80-120%

Alternative Names

M1R, Monkeypox virus/MPXV

Shipping

2-8 ℃

Note

For Research Use Only.

Data Image
  • Experiment Example
    CALCULATION OF RESULTS
    Average the duplicate readings for each standard and sample. Construct a standard curve by plotting the mean absorbance for each standard on the Y-axis against the concentration on the X-axis and draw a best fit curve through the points on the graph. The data may be linearized by plotting the log of the Human Anti-Monkeypox virus IgG (M1R) concentrations versus the log of the O.D. and the best fit line can be determined by regression analysis. This procedure will produce an adequate but less precise fit of the data.
    If samples have been diluted, the concentration read from the standard curve must be multiplied by the dilution factor.
References

Inhibition of monkeypox virus replication by RNA interference. PMID: 19889227

Monkeypox virus viral chemokine inhibitor (MPV vCCI), a potent inhibitor of rhesus macrophage inflammatory protein-1. PMID: 18639466

Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease. PMID: 26147658

Comparative live bioluminescence imaging of monkeypox virus dissemination in a wild-derived inbred mouse (Mus musculus castaneus) and outbred African dormouse (Graphiurus kelleni). PMID: 25462355

Substrate specificity of homogeneous monkeypox virus uracil-DNA glycosylase. PMID: 17910420

The First Case of Monkeypox in the Republic of Korea. PMID: 35818706

Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. PMID: 15919938

[Present status of monkeypox]. PMID: 10549024

Susceptibility of monkeypox virus aerosol suspensions in a rotating chamber. PMID: 23142251

[Development of the disease in marmot at the intranasal infection with the monkeypox virus]. PMID: 27024916

Monoclonal antibodies to a monkeypox virus polypeptide determinant. PMID: 6207310

The relevance of multiple clinical specimens in the diagnosis of monkeypox virus, Spain, June 2022. PMID: 35983771

The presumed receptivity and susceptibility to monkeypox of European animal species. PMID: 35753629

Geographic structuring and divergence time frame of monkeypox virus in the endemic region. PMID: 35831941

Transmissibility of the monkeypox virus clades via respiratory transmission: investigation using the prairie dog-monkeypox virus challenge system. PMID: 23408990

Genome Sequences of Akhmeta Virus, an Early Divergent Old World Orthopoxvirus. PMID: 29757202

Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection. PMID: 21752919

Finishing monkeypox genomes from short reads: assembly analysis and a neural network method. PMID: 27585810

Monkeypox: What do we know so far? A short narrative review of literature. PMID: 35833402

Monkeypox and its pandemic potential: what the anaesthetist should know. PMID: 35803753

Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. PMID: 12149352

Laboratory studies on monkeypox virus. PMID: 6292283

Human monkeypox outbreak caused by novel virus belonging to Congo Basin clade, Sudan, 2005. PMID: 20875278

Diagnosis and assessment of monkeypox virus (MPXV) infection by quantitative PCR assay: differentiation of Congo Basin and West African MPXV strains. PMID: 18362406

LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox. PMID: 16698998

Appearance and re-appearance of zoonotic disease during the pandemic period: long-term monitoring and analysis of zoonosis is crucial to confirm the animal origin of SARS-CoV-2 and monkeypox virus. PMID: 35658858

Cytokine modulation correlates with severity of monkeypox disease in humans. PMID: 25600603

Evaluation of monkeypox virus infection of black-tailed prairie dogs (Cynomys ludovicianus) using in vivo bioluminescent imaging. PMID: 24779460

Independent evolution of monkeypox and variola viruses. PMID: 1331540

New methylene blue derivatives suggest novel anti-orthopoxviral strategies. PMID: 33992710

Ecological niche and geographic distribution of human monkeypox in Africa. PMID: 17268575

Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge. PMID: 18077063

Whitepox virus isolated from hamsters inoculated with monkeypox virus. PMID: 213730

How does monkeypox spread? What scientists know. PMID: 35953575

Monkeypox transmission and pathogenesis in prairie dogs. PMID: 15109408

Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques. PMID: 22001879

Human monkeypox--Kasai Oriental, Zaire, 1996-1997. PMID: 9132583

Elucidating the role of the complement control protein in monkeypox pathogenicity. PMID: 22496894

Varicella Coinfection in Patients with Active Monkeypox in the Democratic Republic of the Congo. PMID: 28894977

The evolving epidemiology of viral encephalitis. PMID: 16914972

DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge. PMID: 17507071

Human monkeypox: secondary attack rates. PMID: 2844429

Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. PMID: 19349521

A novel respiratory model of infection with monkeypox virus in cynomolgus macaques. PMID: 21389129

Datasheet
$ 1128
Product specifications
96T 1128

Contact Information

Order: order@antibodysystem.com

Mail: info@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Human Anti-Monkeypox Virus (MPXV) IgG ELISA Kit (M1R) [KAV13301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2023 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only